PUBLISHER: TechSci Research | PRODUCT CODE: 1101527
PUBLISHER: TechSci Research | PRODUCT CODE: 1101527
We offer 8 hour analyst time for an additional research. Please contact us for the details.
Asia-Pacific cancer diagnostics market is expected to grow at a steady CAGR during the forecast period on account of the increasing trend of unhealthy diet amongst the population and the growing number of cancer cases in the region. This, in turn, is propelling the market growth. Furthermore, growing efforts undertaken by the government to create awareness regarding cancer, as well as to minimize the disease burden, are anticipated to positively impact the growth of the market through 2027. Surging demand for screening tools and techniques is further spurring the growth of the market. However, the high cost of diagnosis might hamper the growth of the market during the forecast period. Furthermore, several side effects associated with imaging solutions are expected to impede the market's growth over the next few years.
The Asia-Pacific cancer diagnostics market is segmented on diagnostic type, technology, application, end-user, company, and country. Based on diagnostic type, the market is categorized into lab testing, genetic testing, imaging testing, biomarkers testing, in vitro diagnostic testing, biopsy, and others. The imaging testing segment dominated the market until 2021 and is expected to dominate the market during the forecast period as well. This dominance can be ascribed to the fact that imaging modalities such as computed tomography scans and magnetic resonance imaging are quick, non-invasive, and pain-free diagnostic solutions. In addition to this, technological advancements in imaging modalities have contributed to the segmental growth. Based on end-user, the market can be fragmented into diagnostic centers, hospitals and clinics, research institutes, and others. The hospitals and clinics segment is expected to dominate the market during the forecast period on account of increased rates of adoption of technologically advanced imaging modalities and other devices which are used in the detection of cancer.
The major players operating in the Asia-Pacific cancer diagnostics market are Thermo Fisher Scientific, Inc., GE Healthcare (A Subsidiary of General Electric Company), Abbott Laboratories, Inc., Becton, Dickinson and Company, Siemens AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Illumina, Inc., Boehringer Ingelheim International GmbH, and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnerships, agreements, and new developments in order to expand their geographic reach and increase customer base.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F-2027F
Objective of the Study:
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of major diagnostic players and hospital chains across the region. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the region.
TechSci Research calculated the market size of the Asia-Pacific cancer diagnostics market using a bottom-up approach, wherein data for various end-user segments were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated them through analyzing historical data of these services for getting an appropriate overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations, and financial reports were also studied by TechSci Research.
Key Target Audience:
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as major diagnostic players and hospital chains, besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, Asia-Pacific cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Lab Testing
Genetic Testing
Imaging Testing
Biomarkers Testing
In Vitro Diagnostic Testing
Biopsy
Others
Platform Based
Instrument Based
Tumor Biomarker Tests
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Kidney Cancer
Skin Cancer
Others
Diagnostic Centers
Hospitals and Clinics
Research Institutes
Others
China
India
Japan
South Korea
Australia
Singapore
Malaysia
Indonesia
Philippines
Thailand
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Asia-Pacific cancer diagnostics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information